Revolutionizing Cancer Treatment: The Incredible Power of Engeneics’ Nanocell Drug Conjugate for Pancreatic Cancer Patients

newscaster03 mins

EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer SYDNEY and NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — EnGeneIC, a pioneer in personalised cancer therapeutics, announces the publication of its clinical trial results in peer reviewed prestigious journal “Clinical Cancer Research”, published by the American Association for Cancer Research….

Read More

Rev Up Your Ride: Kano Laboratories Unveils Must-Have Automotive and Industrial Penetrants at SEMA Show 2023 in Las Vegas!

ilikefinance05 mins

Meet Mr. Kroil: The Unsung Hero of Rusted Nuts and Bolts A Blast from the Past Founded in 1939 and based in Nashville, Tennessee, Kano is the producer of iconic, Kroil-branded penetrating oils and Kano industrial-grade specialty chemicals. Kroil products are consistently used by auto professionals and enthusiasts to loosen rusted and frozen mechanical parts….

Read More

Last Call to Join the Class Action Lawsuit Against Levi and Korsinsky! Don’t Miss Out – Deadline is March 25, 2025

marketsgonewild05 mins

Suffered a Loss on Your Novo Nordisk A/S (NVO) Investment? Here’s What You Need to Know If you’ve recently experienced a financial loss as a result of investing in Novo Nordisk A/S (NVO) and are wondering if you have grounds for recovery under federal securities laws, you’re not alone. The securities fraud law firm Zimmerman…

Read More

Title: Secretary Doug Burgum of the US Interior to Speak at CERAWeek by S&P Global in Houston: March 10-14 – A Peek into the Political Agenda for Energy

financenews04 mins

CERAWeek by S&P Global: Moving Ahead with Complex Energy Strategies The energy industry is gearing up for one of the most anticipated events of the year: the 43rd annual CERAWeek conference, hosted by S&P Global. This prestigious gathering, scheduled for March 10-14, 2025, in Houston, Texas, brings together industry leaders, experts, and policymakers to discuss…

Read More

“Join the Fight Against Securities Fraud: CDLX Investors Have a Chance to Lead the Way with the Schall Law Firm”

marketinsider03 mins

Investors Have Opportunity to Lead Securities Fraud Lawsuit Against Cardlytics, Inc. Overview Recently, the Schall Law Firm announced that investors have the opportunity to lead a securities fraud lawsuit against Cardlytics, Inc. This lawsuit comes as a result of alleged fraudulent activities carried out by the company, impacting its investors and shareholders. The Allegations The…

Read More

Revolutionizing Pancreatic Cancer Treatment: AIM Immunotech’s Ampligen Phase 2 Study Now Recruiting Patients!

newscaster04 mins

Ongoing Efforts to Open Additional Clinical Sites for Recruitment at Premier Cancer Centers Across the U.S. and Europe Facilitating Patient Enrollment and Dosing for Pancreatic Cancer Treatment Study OCALA, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) AIM ImmunoTech Inc. has recently announced the launch of a Phase 2 study…

Read More